Effect of Intratympanic injection of dexamethasone via catheter in Sudden Sensory Neural Hearing Loss

Not Applicable

• Conditions: Sudden Sensory-Neural Hearing Loss (SSNHL).; Sudden idiopathic hearing loss, unspecified ear; H91.20

• Registration Number: IRCT20211125053181N2
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Adult age (18-75 age old)
Hearing loss greater than 60db based on SRT
In the first two weeks of the disease

Exclusion Criteria

Lack of consent for treatment at any stage
Presence of active infectious ear disease
Referral more than a month after the onset of the disease
Presence of other causes of hearing loss (ear tumor, toxic drugs, sound trauma, ear surgery)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hearing threshold pure tone (PTA) and speech reception threshold (SRT) in the initial audiometry and then their changes in the follow-up period. Timepoint: At the beginning of the study and 14, 30, 90 days after the start of treatment. Method of measurement: Pure tone audiometry (PTA) and assessment of changes in speech perception threshold (SRT) before and after treatment.